Pfohl M, Schatz H
Medizinische Klinik und Poliklinik, BG-Kliniken Bergmannsheil, Universitätsklinik, Bochum, Germany.
Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S240-9. doi: 10.1055/s-2001-18585.
Type 2 diabetes is a common chronic disease affecting more than 100 millions of people world-wide, and is a major cause of premature morbidity and mortality. Macrovascular disease and its risk factors are often already present in individuals at risk for type 2 diabetes, and some of the risk factors for the development of type 2 diabetes, such as obesity, physical inactivity, and high-fat diet, can potentially be modified. Because some of the metabolic abnormalities, such as insulin resistance or impaired glucose tolerance, that indicate a risk for diabetes can be improved by lifestyle modification and drug treatment, strategies for the prevention of type 2 diabetes appear to be necessary for affected individuals. Several clinical trials have addressed the hypothesis that type 2 diabetes can be prevented by dietary modification, physical activity, or drug treatment. Although some of these studies indicate a protective effect of these measures against the development of type 2 diabetes in people at risk, many of their conclusions are limited with respect to randomisation, sample size, or intensity of the intervention. In the large prospective Da Qing study (1997), both dietary and physical activity interventions reduced the incidence of type 2 diabetes considerably in a Chinese population. Whether this is also achievable in other ethnic populations at high risk for developing type 2 diabetes, and whether additional pharmacological measures are useful, is currently under investigation.
2型糖尿病是一种常见的慢性病,全球有超过1亿人受其影响,是过早发病和死亡的主要原因。大血管疾病及其危险因素在2型糖尿病高危个体中往往已经存在,而2型糖尿病发生的一些危险因素,如肥胖、缺乏体育活动和高脂饮食,有可能得到改善。由于一些表明糖尿病风险的代谢异常,如胰岛素抵抗或糖耐量受损,可通过生活方式改变和药物治疗得到改善,因此对于受影响个体而言,预防2型糖尿病的策略似乎是必要的。几项临床试验探讨了通过饮食调整、体育活动或药物治疗可预防2型糖尿病这一假设。尽管其中一些研究表明这些措施对高危人群发生2型糖尿病具有保护作用,但其许多结论在随机化、样本量或干预强度方面存在局限性。在大型前瞻性大庆研究(1997年)中,饮食和体育活动干预均显著降低了中国人群中2型糖尿病的发病率。目前正在研究这在其他2型糖尿病高危种族人群中是否也能实现,以及额外的药物措施是否有用。